• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Loratadim
    / CTS


    Active Ingredient
    Loratadine 10 mg

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    10 X 10 mg

    full basket chart 30383 12024

    Tablets

    20 X 10 mg

    full basket chart 5134 12074

    Related information


    Dosage

    One tablet a day.


    Indications

    Seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.


    Contra-Indications

    Known hypersensitivity, newborn or premature babies, lactation, asthma or other lower respiratory tract conditions, narrow-angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction, concomitant use with monoamine oxidase inhibitor therapy.


    Special Precautions

    Safety of use in pregnancy has not been established. The drug should therefore be used during pregnancy only if clearly needed. Drowsiness, history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, hypertension.


    Side Effects

    Drowsiness, lassitude, giddiness, epigastric distress, dryness of mouth, blurred vision, cardiac palpitations, flushing, increased irritability or excitement (especially in children).


    Drug interactions

    Alcohol, CNS depressants, anticholinergics.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE